GlassScriptPhysician profile
Robert Frykberg
NPI 1649295858
$6,450.41
in general payments reported to CMS, 2019-2025
13 companies · $3,877 in 2025
The $3,877 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $600 · 2022: $1,499 · 2023: $197 · 2024: $278 · 2025: $3,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,434 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,434.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
| Education | $316.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,677.67 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Advanced Oxygen Therapy INC. | $1,714.12 | 2022-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Partner Therapeutics, INC. | $600.00 | 2021 | |
| Stryker Corporation | $270.69 | 2025 | N/A, Infinity Adaptis, Augment Injectable |
| Smith+Nephew, INC. | $268.43 | 2023-2025 | Grafix Pl, Collagenase Santyl |
| Ets Wound Care LLC | $258.59 | 2024 | Mirragen Advanced Wound Matrix |
| Organogenesis INC. | $181.37 | 2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 | |
| Paratek Pharmaceuticals, INC. | $124.99 | 2025 | Nuzyra |
| Globus Medical, INC. | $120.87 | 2025 | Senza |
| Averitas Pharma INC. | $67.35 | 2025 | Qutenza |
| Integra Lifesciences Corporation | $22.30 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Novo Nordisk INC | $19.04 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Frykberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.